Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Isthmus Partners LLC

Isthmus Partners LLC raised its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 17.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 75,761 shares of the specialty pharmaceutical company’s stock after acquiring an additional 11,289 shares during the period. Isthmus Partners LLC’s holdings in Supernus […]

Leave a Reply

Your email address will not be published.

Previous post Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stake Raised by Isthmus Partners LLC
Next post W.W. Grainger, Inc. (NYSE:GWW) Stock Holdings Lessened by Isthmus Partners LLC